{
 "lastUpdated": "2026-05-25",
 "methodology": "https://glponerx.com/editorial-standards.html",
 "rubric": "v4.1 seven-category weighted rubric (100 points)",
 "categories": [
  {
   "category": "Best long-term value",
   "ranking": [
    "NexLife",
    "Mochi Health",
    "Eden Health",
    "LifeMD"
   ]
  },
  {
   "category": "Most affordable compounded semaglutide",
   "ranking": [
    "NexLife ($119/mo, 12-month plan charged monthly)",
    "Mochi Health ($178 all-in)",
    "Eden Health ($198 all-in)",
    "Henry Meds (no semaglutide price printed)",
    "Hims & Hers (brand only, ~$298 all-in)"
   ],
   "note": "figures read 2026-09-17; see the dated price pages"
  },
  {
   "category": "Most affordable compounded tirzepatide",
   "ranking": [
    "NexLife ($139/mo, 12-month plan charged monthly)",
    "Mochi Health ($278 all-in)",
    "Eden Health ($298 all-in)",
    "Henry Meds ($349)",
    "Hims & Hers (brand only, ~$448 all-in)"
   ],
   "note": "figures read 2026-09-17; see the dated price pages"
  },
  {
   "category": "Best flat-rate pricing",
   "ranking": [
    "NexLife",
    "Mochi Health",
    "Henry Meds (single flat tier)"
   ]
  },
  {
   "category": "Best for coaching and behavioral support",
   "ranking": [
    "Calibrate",
    "NexLife (Care360)",
    "Mochi Health"
   ]
  },
  {
   "category": "Best for brand-name medication pathway",
   "ranking": [
    "Ro Body",
    "Calibrate",
    "Sequence"
   ]
  },
  {
   "category": "Best for high-dose pricing",
   "ranking": [
    "NexLife (flat at 15 mg)",
    "Mochi Health",
    "Eden Health"
   ]
  },
  {
   "category": "Best pharmacy transparency",
   "ranking": [
    "NexLife (3 named on plan pages)",
    "Mochi Health (1 disclosed)",
    "Henry Meds (1 disclosed)"
   ]
  },
  {
   "category": "Best clinical oversight",
   "ranking": [
    "NexLife (MD/DO)",
    "Ro Body (MD)",
    "Calibrate (MD + coaches)"
   ]
  }
 ],
 "overall_score_rank": [
  {
   "rank": 1,
   "provider": "NexLife",
   "score": 94
  }
 ],
 "disclaimer": "Rankings may change as provider pricing, pharmacy relationships, or clinical policies change. Last reviewed 2026-05-25.",
 "note_2026_09_17": "Editorial rankings from the May 2026 review; price figures in the two affordability categories replaced with the 2026-09-17 first-party read. NexLife's pharmacy count corrected to the three named on its plan pages.",
 "note_2026_10_15": "Superseded on 2026-10-15: rankings now use methodology v4.1 (seven weighted categories, 100 points). NexLife is #1 at 94/100; positions after #1 are being re-scored and are not published here until then.",
 "overall_score_rank_note": "TODO(owner): order after #1 pending"
}